Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
278
278 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CRT-402Phase 21 trial
Myeloid Therapeutics · Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma
- CS32582Phase 21 trial
Chipscreen Biosciences, Ltd. · Plaque Psoriasis
- DA-020Phase 21 trial
Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects
- DB-2304Phase 21 trial
DualityBio Inc. · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
- DS-7011aPhase 21 trial
Daiichi Sankyo · Systemic Lupus Erythematosus
- E6742Phase 21 trial
Eisai · Systemic Lupus Erythematosus
- EB06Phase 21 trial
Edesa Biotech Inc. · Non-Segmental Vitiligo (NSV)
- EG-501EG-MNTP-01Phase 21 trial
Evergreen Therapeutics, Inc. · Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment
- EI-001Phase 21 trial
Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo
- ELV001Phase 21 trial
Elevara Medicines Limited · Active Rheumatoid Arthritis
- EPI-001Phase 21 trial
Epibiotech · Androgenetic Alopecia
- EVO301Phase 21 trial
Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
- FT819Phase 21 trial
Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus
- FT839Phase 21 trial
Fate Therapeutics · ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA)
- GarutadustatISM5411Phase 21 trial
InSilico Medicine Hong Kong Limited · Ulcerative Colitis
- GenSci120Phase 21 trial
Changchun GeneScience Pharmaceutical Co., Ltd. · Rheumatoid Arthritis
- GHZ339Phase 21 trial
Novartis · Atopic Dermatitis
- HB0017Phase 21 trial
Huabo Biopharm Co., Ltd. · Psoriasis (PsO)
- HB0034Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Generalized Pustular Psoriasis (GPP)
- HL-300Phase 21 trial
Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis
- HLX01Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HLX79Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HRS-3095Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria
- HRS-7085Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis
- HS-10374Phase 21 trial
Hansoh BioMedical R&D Company · Psoriasis
- HS-10561Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria
- HS-20118Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis
- HW201877Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)
- HXN6005Phase 21 trial
Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)
- IBI3002Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- IBI355Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Sjögren's Disease
- INT-210Phase 21 trial
Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)
- iscalimabCFZ533Phase 21 trial
Novartis · Hidradenitis Suppurativa
- JNJ-88545223Phase 21 trial
Johnson & Johnson (Janssen) · Arthritis, Psoriatic
- LAD191Phase 21 trial
Almirall, S.A. · Hidradenitis Suppurativa
- LAD328Phase 21 trial
Almirall, S.A. · Hidradenitis Suppurativa
- LAD603Phase 21 trial
Almirall, S.A. · Alopecia Areata
- LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial
LEO Pharma · Atopic Dermatitis
- LesigerceptPhase 21 trial
Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)
- LY3871801Phase 21 trial
Eli Lilly · Rheumatoid Arthritis
- LY3972406Phase 21 trial
Eli Lilly · Plaque Psoriasis
- LY4100511Phase 21 trial
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Plaque Psoriasis
- LYS006Phase 21 trial
Novartis · Hidradenitis Suppurativa
- MB-001Phase 21 trial
Mage Biologics · Ulcerative Colitis (UC)
- MGT-006Phase 21 trial
Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
- MK-8690PRA052Phase 21 trial
Merck & Co. · Colitis Ulcerative, Ulcerative Colitis
- MT-201Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- MT-501Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- NAV-240Phase 21 trial
Navigator Medicines, Inc. · Hidradenitis Suppurativa (HS)
- NN2802Phase 21 trial
Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.